Analyzing Akanda (NASDAQ:AKAN) and Stryker (NYSE:SYK)

Akanda (NASDAQ:AKAN) and Stryker (NYSE:SYK) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Akanda and Stryker, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akanda	1	0	0	0	1.00
Stryker	0	6	16	0	2.73

Stryker has a consensus target price of $395.33, suggesting a potential upside of 28.10%. Given Stryker’s stronger consensus rating and higher possible upside, analysts plainly believe Stryker is more favorable than Akanda.

Institutional and Insider Ownership

1.0% of Akanda shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 20.4% of Akanda shares are held by insiders. Comparatively, 4.6% of Stryker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Akanda has a beta of 14.02, suggesting that its stock price is 1,302% more volatile than the S&P 500. Comparatively, Stryker has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Profitability

This table compares Akanda and Stryker’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Akanda	N/A	N/A	N/A
Stryker	13.20%	23.42%	11.04%

Valuation and Earnings

This table compares Akanda and Stryker”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akanda	$258,075.00	38.15	-$45.65 million	N/A	N/A
Stryker	$25.12 billion	4.71	$3.25 billion	$8.64	35.72

Stryker has higher revenue and earnings than Akanda.

Summary

Stryker beats Akanda on 9 of the 12 factors compared between the two stocks.

About Akanda

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.